DICE Therapeutics, Inc.
DICE · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,816 | -$25,646 | -$23,224 | -$20,550 |
| Dep. & Amort. | $687 | $630 | $609 | $595 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,503 | $4,889 | $3,343 | $3,465 |
| Change in WC | $2,753 | $60 | $1,092 | $1,068 |
| Other Non-Cash | -$2,703 | -$2,369 | $288 | $98 |
| Operating Cash Flow | -$28,576 | -$22,436 | -$17,892 | -$15,324 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,829 | -$202 | -$437 | -$524 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$53,963 | -$397,724 | -$44,606 | -$29,140 |
| Inv. Sales/Matur. | $55,000 | $60,271 | $106,415 | $76,500 |
| Other Inv. Act. | $0 | $0 | $44,606 | $0 |
| Investing Cash Flow | -$792 | -$337,655 | $105,978 | $46,836 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $351 | $323,710 | $0 |
| Stock Repurch. | $4,828,189 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,828,189 | $292 | $325,036 | -$8 |
| Financing Cash Flow | $1,238 | $292 | $325,036 | -$8 |
| Forex Effect | $4,856,319 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28,130 | -$359,799 | $413,122 | $31,504 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $101,792 | $461,591 | $48,469 | $16,965 |
| End Cash | $73,662 | $101,792 | $461,591 | $48,469 |
| Free Cash Flow | -$30,405 | -$22,638 | -$18,329 | -$15,848 |